PIM kinases are progression markers and emerging therapeutic targets in diffuse large B-cell lymphoma.

Br J Cancer · 2012 · PMC3405213 · PMID 22722314

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although co-expression of all three PIM kinases was more prevalent in the non-GC-derived cases, the distribution differences between GC- and non-GC cases, as defined by either the Choi- or the Hans-algorithm ( Hans et al , 2004 ; Choi et al , 2009 ), did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.